Summary
0.31 0.01(3.33%)07/14/2025
NKGen Biotech, Inc. Common Stock (NKGN)
NKGN reported last earnings on 2025-03-04 after the market. An EPS of $0.15 was observed compared to an estimated EPS of $, resulting in a surprise value of $0.15. A revenue of $0 million was observed compared to an estimated revenue of $0 million, resulting in a surprise value of $0 Million.
NKGen Biotech, Inc. Common Stock (NKGN)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| -12.90 | 0.00 | 0.00 | 158.33 | -34.18 | -66.67 | 0.00 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Earnings
| Trading Data | ||
| Close | 0.27 | |
| Open | 0.30 | |
| High | 0.30 | |
| Low | 0.27 | |
| Volume | 99,732 | |
| Change | -0.04 | |
| Change % | -12.90 | |
| Avg Volume (20 Days) | 144,309 | |
| Volume/Avg Volume (20 Days) Ratio | 0.69 | |
| 52 Week Range | 0.10 - 1.37 | |
| Price vs 52 Week High | -80.29% | |
| Price vs 52 Week Low | 175.51% | |
| Range | 0.00 | |
| Gap Up/Down | 0.01 | |
Profitibility | ||
| Market Capitalization (Mln) | 25 | |
| Revenue per share | 0.0000 | |
| Net Income per share | -1.6640 | |
| Dividend Yield | 0.0000 | |
| Dividend Share | 0.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | -0.1863 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |